Key Takeaways: Women need a different testosterone testing panel than men, with more sensitive assays and additional markers like DHEA-S, SHBG, and progesterone. Normal reference ranges for women are roughly 1/10th of male ranges, and the difference between "normal" and "optimal" can mean the difference between feeling fine and feeling terrible. Timing matters -- test on days 3-7 of your menstrual cycle, fasting, before 10 AM.
Most women who suspect low testosterone run into the same problem: their doctor orders the wrong tests, uses the wrong assay, or interprets results against male-calibrated reference ranges. The result is a lab report that says "normal" when the patient clearly is not.
Women's testosterone testing requires a specific panel, specific timing, and specific interpretation. This guide covers exactly what to order, when to draw blood, and what the numbers actually mean.
Why Standard Testing Fails Women
The testosterone testing infrastructure was built for men. Most commercial immunoassays are calibrated for male ranges (300-1000 ng/dL) and lose accuracy at the low concentrations found in women (15-70 ng/dL for total testosterone). A test with a margin of error of +/- 50 ng/dL is irrelevant for a man at 500 ng/dL but catastrophic for a woman at 30 ng/dL.
This is not theoretical. The Endocrine Society has explicitly stated that standard immunoassays are unreliable for measuring testosterone in women and recommends liquid chromatography-tandem mass spectrometry (LC-MS/MS) as the preferred method (PMID: 25279570). If your lab report does not specify the assay method, ask. If they used a standard immunoassay, the result may be meaningless.
Beyond the assay problem, reference ranges on lab reports are generated from population averages that include women on oral contraceptives (which suppress testosterone) and women with PCOS (which elevates it). These ranges are so wide they capture almost everyone as "normal."
The Complete Women's Testosterone Panel
Do not order a single testosterone test and call it done. Testosterone in women is influenced by SHBG, adrenal function, and ovarian output. You need the full picture.
Essential Tests (Non-Negotiable)
Total Testosterone (via LC-MS/MS) The foundation. Measures all testosterone in your blood -- bound and unbound. In premenopausal women, expect 15-70 ng/dL. The key is ensuring the lab uses LC-MS/MS, not standard immunoassay.
Free Testosterone (calculated or equilibrium dialysis) This is what actually matters for symptoms. Only 1-3% of total testosterone is free and available to tissues. The rest is bound to SHBG (65-80%) or albumin (20-30%). Equilibrium dialysis is the gold standard; calculated free testosterone using the Vermeulen equation is an acceptable alternative.
Sex Hormone-Binding Globulin (SHBG) The gatekeeper. SHBG binds testosterone and renders it inactive. High SHBG means less free testosterone regardless of your total level. Oral contraceptives, thyroid medication, liver conditions, and low-calorie diets all raise SHBG. This single marker explains why many women have "normal" total testosterone but low-testosterone symptoms.
DHEA-S (Dehydroepiandrosterone Sulfate) Your adrenal androgen marker. About 50% of a woman's androgens originate from adrenal precursors, primarily DHEA and DHEA-S, which are converted to testosterone in peripheral tissues (PMID: 9253307). DHEA-S declines roughly 2-3% per year starting in the mid-20s. By menopause, most women have lost 60% or more of their peak DHEA-S. If DHEA-S is low alongside low testosterone, the problem is likely adrenal rather than ovarian.
Critical Complementary Markers
Estradiol (E2) Testosterone and estradiol work together. Estradiol levels contextualize testosterone results -- the ratio between them matters as much as the individual values. In premenopausal women, estradiol fluctuates significantly across the cycle, so interpreting it requires knowing when in the cycle the blood was drawn.
Progesterone Confirms ovulation when drawn in the luteal phase (days 19-22). Low progesterone suggests anovulatory cycles, which are often linked to broader hormonal disruption including androgen imbalance. On days 3-7 (when you test testosterone), progesterone should be low -- if it is elevated, the timing is off.
Prolactin Elevated prolactin suppresses the entire hypothalamic-pituitary-gonadal axis, including testosterone production. Rule it out before attributing low testosterone to aging or menopause.
Thyroid Panel (TSH + Free T4) Hypothyroidism mimics many low-testosterone symptoms (fatigue, brain fog, weight gain, low libido) and also affects SHBG levels. Always check.
When to Test: Cycle Timing Is Everything
For premenopausal women, testosterone fluctuates across the menstrual cycle. Testing at the wrong time produces misleading results.
The Testing Window: Days 3-7
Draw blood during the early follicular phase (days 3-7 of your cycle), counting day 1 as the first day of your period. This window provides the most stable baseline testosterone reading.
Testosterone rises toward mid-cycle, peaking around ovulation (days 12-14) before declining in the luteal phase. A mid-cycle draw can show a level 20-30% higher than your true baseline. An ovulation-day draw may show your "peak" rather than your average.
Other Timing Rules
- Morning draw (before 10 AM). Testosterone follows a diurnal rhythm in women, though the variation is less pronounced than in men. Morning levels are the most reproducible.
- Fasting (8-12 hours). Glucose intake acutely suppresses testosterone. Water and black coffee are fine.
- Avoid testing during acute illness, extreme stress, or significant sleep deprivation. All temporarily suppress the HPG axis.
- If on oral contraceptives: Understand that your results will show suppressed free testosterone due to elevated SHBG. This is the pill's pharmacological effect, not your natural baseline. For accurate baseline assessment, test 6-8 weeks after discontinuation.
Postmenopausal Women
Cycle timing is irrelevant after menopause. Test any morning, fasting, before 10 AM. The same panel applies. Expect lower total and free testosterone compared to premenopausal ranges.
Perimenopause
This is the most challenging testing scenario. Cycles become irregular, making it difficult to identify day 3-7. If your cycles are unpredictable, draw blood during any light-flow or early-bleed day. If periods have stopped for 2+ months, treat it as postmenopausal timing.
Normal vs. Optimal Ranges: What the Numbers Mean
Here is where most confusion lives. Lab reference ranges and clinical optimal ranges are not the same thing.
Reference ranges represent the 2.5th to 97.5th percentile of the tested population. Being "in range" means you fall somewhere within 95% of the population -- including people who feel terrible. Optimal ranges represent where most women report feeling their best, based on clinical outcomes data and the 2019 Global Consensus Position Statement (PMID: 31488288).
Premenopausal Women (Ages 18-45)
| Marker | Lab Reference Range | Optimal Range | Unit |
|---|---|---|---|
| Total Testosterone | 8-60 ng/dL | 30-50 ng/dL | ng/dL |
| Free Testosterone | 0.5-5.0 pg/mL | 2.0-4.0 pg/mL | pg/mL |
| SHBG | 18-144 nmol/L | 40-80 nmol/L | nmol/L |
| DHEA-S | 65-380 mcg/dL | 150-300 mcg/dL | mcg/dL |
| Estradiol (follicular) | 15-350 pg/mL | 30-100 pg/mL | pg/mL |
| Progesterone (luteal) | 1.8-24 ng/mL | 10-20 ng/mL | ng/mL |
| Prolactin | 2-29 ng/mL | 5-20 ng/mL | ng/mL |
Postmenopausal Women
| Marker | Lab Reference Range | Optimal Range | Unit |
|---|---|---|---|
| Total Testosterone | 5-32 ng/dL | 15-25 ng/dL | ng/dL |
| Free Testosterone | 0.2-3.0 pg/mL | 1.0-2.5 pg/mL | pg/mL |
| SHBG | 20-130 nmol/L | 30-70 nmol/L | nmol/L |
| DHEA-S | 30-260 mcg/dL | 100-200 mcg/dL | mcg/dL |
| Estradiol | <10-40 pg/mL | Depends on HRT status | pg/mL |
| Prolactin | 2-20 ng/mL | 5-15 ng/mL | ng/mL |
A woman with a total testosterone of 12 ng/dL is technically "in range" for most labs. She is also likely experiencing fatigue, low libido, muscle loss, and brain fog. The number is not clinically optimal -- it is just not flagged.
Reference ranges derived from LC-MS/MS methods in healthy premenopausal women show more useful boundaries (PMID: 21771278, PMID: 22162468). The problem is that most labs still use older immunoassay-based ranges.
